Next Article in Journal / Special Issue
New Conotoxin SO-3 Targeting N-type Voltage-Sensitive Calcium Channels
Previous Article in Journal / Special Issue
Marine Toxins That Target Voltage-gated Sodium Channels
Article Menu

Export Article

Open AccessReview
Mar. Drugs 2006, 4(3), 193-214; doi:10.3390/md403193

ω-Conotoxins GVIA, MVIIA and CVID: SAR and Clinical Potential

Institute for Molecular Bioscience, The University of Queensland, St Lucia, 4072, QLD, Australia
*
Author to whom correspondence should be addressed.
Received: 16 February 2006 / Accepted: 28 February 2006 / Published: 6 April 2006
(This article belongs to the Special Issue Marine Drugs and Ion Channels)
View Full-Text   |   Download PDF [419 KB, uploaded 24 February 2015]   |  

Abstract

Highly selective N-type voltage-gated calcium (CaV) channel inhibitors from cone snail venom (the ω-conotoxins) have emerged as a new class of therapeutics for the treatment of chronic and neuropathic pain. Earlier in 2005, Prialt (Elan) or synthetic ω-conotoxin MVIIA, was the first ω-conotoxin to be approved by Food and Drug Administration for human use. This review compares the action of three ω-conotoxins, GVIA, MVIIA and CVID, describing their structure-activity relationships and potential as leads for the design of improved N-type therapeutics that are more useful in the treatment of chronic pain.
Keywords: ω-conotoxin; Structure-Activity relationship; pain ω-conotoxin; Structure-Activity relationship; pain
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Schroeder, C.I.; Lewis, R.J. ω-Conotoxins GVIA, MVIIA and CVID: SAR and Clinical Potential. Mar. Drugs 2006, 4, 193-214.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top